Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin / 한국유방암학회지
Journal of Breast Cancer
;
: 141-148, 2019.
Artigo
em Inglês
| WPRIM
| ID: wpr-738408
ABSTRACT
The luteinizing hormone-releasing hormone/androgen receptor (LHRH/AR) pathway is a promising treatment target in a subgroup of female patients with triple-negative breast cancer (TNBC). However, very little is known about the efficacy of this strategy in male patients with TNBC. In this report, we describe a male patient with AR-positive TNBC who was successfully treated using an LHRH agonist after pretreatment with several lines of chemotherapy and achieved a durable response. We also review the existing evidence supporting LHRH- and AR-targeted therapy for this rare disease.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Luteína
/
Receptores Androgênicos
/
Hormônio Liberador de Gonadotropina
/
Gosserrelina
/
Neoplasias da Mama Masculina
/
Doenças Raras
/
Tratamento Farmacológico
/
Neoplasias de Mama Triplo Negativas
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Journal of Breast Cancer
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS